Pancreatic Cancer Research

ResearcherDalian Medical UniversityActive in the last 2 years

Biao Zhang

Matched on ORCID iD 0000-0001-6097-1878; OpenAlex author ID A5100363708. Sources: OpenAlex.

Their work

Papers
13 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
15
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper · 2023: 4 papers · 2024: 3 papers · 2025: 2 papers · 2026: 2 papers

Papers 13

  1. Correction: Molecular mechanisms of RACK1-driven metastasis in pancreatic ductal adenocarcinoma revealed by single-cell RNA sequencing. Co-author DOI 10.1007/s12672-026-05467-2↗
  2. Commentary on "Intercellular TIMP-1-CD63 signaling directs the evolution of immune escape and metastasis in KRAS-mutated pancreatic cancer cells". Co-author DOI 10.1186/s12943-026-02656-z↗
  3. Molecular mechanisms of RACK1-driven metastasis in pancreatic ductal adenocarcinoma revealed by single-cell RNA sequencing. Co-author DOI 10.1007/s12672-025-03679-6↗
  4. The Molecular Characteristics and Therapeutic Implications of O-glycan Synthesis in Pancreatic Cancer by Integrating Transcriptome and Single-cell Data. First author DOI 10.2174/0109298673293445240409060446↗
  5. Integrated bulk and single-cell profiling characterize sphingolipid metabolism in pancreatic cancer. Co-author DOI 10.1186/s12885-024-13114-8↗
  6. A stumbling block in pancreatic cancer treatment: drug resistance signaling networks. First author DOI 10.3389/fcell.2024.1462808↗
  7. Identification of basement membrane-related prognostic model associated with the immune microenvironment and synthetic therapy response in pancreatic cancer: i… Co-author DOI 10.7150/jca.100891↗
  8. Integrated single-cell and bulk RNA sequencing revealed the molecular characteristics and prognostic roles of neutrophils in pancreatic cancer. Co-author DOI 10.18632/aging.205044↗
  9. Identifying endoplasmic reticulum stress-related molecular subtypes and prognostic model for predicting the immune landscape and therapy response in pancreatic… Co-author DOI 10.18632/aging.205094↗
  10. PANoptosis-related molecular subtype and prognostic model associated with the immune microenvironment and individualized therapy in pancreatic cancer. Co-author DOI 10.3389/fonc.2023.1217654↗
  11. Integrated multi-omics identified the novel intratumor microbiome-derived subtypes and signature to predict the outcome, tumor microenvironment heterogeneity, … Co-author DOI 10.3389/fphar.2023.1244752↗
  12. Characterization of neuroendocrine regulation- and metabolism-associated molecular features and prognostic indicators with aid to clinical chemotherapy and imm… Co-author DOI 10.3389/fendo.2022.1078424↗
  13. Circulating leptin and adiponectin levels in patients with pancreatic cancer. Co-author DOI 10.1097/cm9.0000000000001509↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Dong Shang · 8 shared papers, 2021–2026 · strength 2.31
  2. Huiyi Song · 4 shared papers, 2023–2026 · strength 1.07
  3. Xu Chen · 5 shared papers, 2021–2023 · strength 0.87
  4. Hangyu Liu · 3 shared papers, 2022–2026 · strength 0.82
  5. Zhizhou Wang · 4 shared papers, 2022–2024 · strength 0.78
  6. Qihang Yuan · 4 shared papers, 2021–2025 · strength 0.75
  7. Shilin Xia · 3 shared papers, 2023–2025 · strength 0.66
  8. Shuang Li · 3 shared papers, 2021–2023 · strength 0.49
  9. Jifeng Liu · 2 shared papers, 2023–2025 · strength 0.44
  10. Dong Shang · 2 shared papers, 2022–2024 · strength 0.37
  11. Binqian Huang · 1 shared paper, 2025 · strength 0.26
  12. Zhizhou Wang · 1 shared paper, 2024 · strength 0.24
  13. Jinming Liu · 1 shared paper, 2024 · strength 0.24
  14. Hui Guo · 1 shared paper, 2023 · strength 0.19
  15. Fangyue Guo · 1 shared paper, 2023 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.